{
  "pmid": "34818492",
  "uid": "34818492",
  "title": "Efpeglenatide and Heart and Kidney Outcomes in Type 2 Diabetes. Reply.",
  "abstract": "",
  "authors": [
    {
      "last_name": "Gerstein",
      "fore_name": "Hertzel C",
      "initials": "HC",
      "name": "Hertzel C Gerstein",
      "affiliations": [
        "McMaster University, Hamilton, ON, Canada gerstein@mcmaster.ca."
      ]
    },
    {
      "last_name": "Khurmi",
      "fore_name": "Nardev S",
      "initials": "NS",
      "name": "Nardev S Khurmi",
      "affiliations": [
        "Sanofi, Bridgewater, NJ."
      ]
    }
  ],
  "journal": {
    "title": "The New England journal of medicine",
    "iso_abbreviation": "N Engl J Med",
    "issn": "1533-4406",
    "issn_type": "Electronic",
    "volume": "385",
    "issue": "22",
    "pub_year": "2021",
    "pub_month": "Nov",
    "pub_day": "25"
  },
  "start_page": "2107",
  "pages": "2107",
  "language": "eng",
  "publication_types": [
    "Letter",
    "Comment"
  ],
  "keywords": [
    "Diabetes Mellitus, Type 2",
    "Glycated Hemoglobin",
    "Humans",
    "Hypoglycemic Agents",
    "Kidney",
    "Proline"
  ],
  "article_ids": {
    "pubmed": "34818492",
    "doi": "10.1056/NEJMc2115776",
    "pii": "10.1056/NEJMc2115776#sa4"
  },
  "doi": "10.1056/NEJMc2115776",
  "dates": {
    "completed": "2021-11-30",
    "revised": "2022-12-07"
  },
  "chemicals": [
    "Glycated Hemoglobin A",
    "Hypoglycemic Agents",
    "efpeglenatide",
    "Proline"
  ],
  "grants": [],
  "search_metadata": {
    "search_type": "current_affiliation",
    "retrieved_date": "2025-07-30T14:22:49.728858",
    "pmid": "34818492"
  }
}